Vicapsys Life Sciences annual operating cash flow
2019
2020
2021
2022
2023
Vicapsys Life Sciences Operating Cash Flow Growth & History (VICP)
Vicapsys Life Sciences's operating cash flow was −$417,524 for fiscal 2023.
View full Vicapsys Life Sciences company overviewVicapsys Life Sciences annual operating cash flow history
| Fiscal year | Period ended | Operating cash flow | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | −$417,524 | −$179,327 | — |
| 2022 | 2022-12-31 | −$238,197 | $205,777 | — |
| 2021 | 2021-12-31 | −$443,974 | −$181,077 | — |
| 2020 | 2020-12-31 | −$262,897 | $707,367 | — |
| 2019 | 2019-12-31 | −$970,264 | — | — |
Vicapsys Life Sciences quarterly operating cash flow
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
| Fiscal quarter | Period ended | Operating cash flow | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | −$40,431 | $66,979 | — |
| Q2 2024 | 2024-06-30 | $6,166 | $224,269 | — |
| Q1 2024 | 2024-03-31 | −$9,422 | $535 | — |
| Q4 2023 | 2023-12-31 | −$82,054 | −$84,942 | — |
| Q3 2023 | 2023-09-30 | −$107,410 | −$66,331 | — |
| Q2 2023 | 2023-06-30 | −$218,103 | −$134,073 | — |
| Q1 2023 | 2023-03-31 | −$9,957 | $106,019 | — |
| Q4 2022 | 2022-12-31 | $2,888 | $126,142 | — |
| Q3 2022 | 2022-09-30 | −$41,079 | $138,996 | — |
| Q2 2022 | 2022-06-30 | −$84,030 | −$14,191 | — |
| Q1 2022 | 2022-03-31 | −$115,976 | −$45,170 | — |
| Q4 2021 | 2021-12-31 | −$123,254 | −$122,869 | — |
| Q3 2021 | 2021-09-30 | −$180,075 | −$176,743 | — |
| Q2 2021 | 2021-06-30 | −$69,839 | −$43,877 | — |
| Q1 2021 | 2021-03-31 | −$70,806 | $162,412 | — |
| Q4 2020 | 2020-12-31 | −$385 | $246,095 | — |
| Q3 2020 | 2020-09-30 | −$3,332 | $338,368 | — |
| Q2 2020 | 2020-06-30 | −$25,962 | $168,384 | — |
| Q1 2020 | 2020-03-31 | −$233,218 | −$45,480 | — |
| Q4 2019 | 2019-12-31 | −$246,480 | — | — |
| Q3 2019 | 2019-09-30 | −$341,700 | — | — |
| Q2 2019 | 2019-06-30 | −$194,346 | — | — |
| Q1 2019 | 2019-03-31 | −$187,738 | — | — |
Vicapsys Life Sciences operating cash flow trends
Between the periods ended 2019-12-31 and 2023-12-31, Vicapsys Life Sciences's operating cash flow increased from −$970,264 to −$417,524, a change of $552,740. The latest reported quarter, Q3 2024, shows −$40,431.
About the metric
What operating cash flow means
Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.
Calculation and source
SEC-reported operating cash flow
TickerStat standardizes net cash provided by or used in operating activities reported in company SEC filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vicapsys Life Sciences source filings ↗